Gain Therapeutics falls after CFO resigns

Gain Therapeutics

22/02/2024 13:51

** Shares of Gain Therapeutics  GANX.O  down 1.6% at $4.4 in
 premarket trading 
    ** Co disclosed in a regulatory filing that its chief
financial officer, C. Evan Ballantyne, resigned on Feb. 19 
    ** Co says Ballantyne has resigned from all positions at
GANX, effective March 1 
    ** GANX has initiated a search to identify the next CFO, as
per the regulatory filing 
    ** Up to last close, stock fell 5.4% YTD 

 (Reporting by Pratik Jain in Bengaluru)
 ((Pratik.Jain@thomsonreuters.com;))